Penny and Phil Knight’s Gift advances research into brain resilience and aging
On May 12, 2026, Stanford University announced a $90 million gift from Penny and Philip H. Knight, MBA…
-
-
Bristol Myers Squibb and Hengrui Pharma Announce Strategic Agreements to Advance Innovative Medicines in Deal Worth $15.2 billion
On May 12, 2026, Bristol Myers Squibb and Hengrui Pharma announced the companies have entered into global strategic…
-
Fujirebio announces CE marking of Lumipulse® G pTau 217 Plasma assay for Alzheimer’s disease
On May 11, 2026, Fujirebio Europe announced that it has obtained a CE certificate of the Lumipulse G…
-
California Dairy Study Raises New Questions About How H5N1 Spreads
On May 8, 2026, researchers detected infectious H5N1 virus in milking parlor air and wastewater systems while also…
-
Angelini Pharma to Acquire Catalyst Pharmaceuticals for $4.1 Billion USD
On May 7, 2026, Angelini Pharma and Catalyst Pharmaceuticals, a commercial-stage biopharmaceutical company focused on in-licensing, developing, and…
-
Thousands of previously unknown proteins discovered
On May 6, 2026, a group of international researchers announced they had discovered 1,700 new proteins. The research…
-
Lilly commits additional $4.5 billion across Indiana manufacturing sites, opens first dedicated genetic medicine facility
On May 6, 2026, Eli Lilly announced an additional $4.5 billion investment across two of its three Lebanon…
-
Roche agrees to acquire US-based PathAI for $1 Billion
On May 6, 2026, Swiss pharmaceutical giant Roche announced it had agreed to acquire U.S.-based digital pathology and…
-
UVA Study Reveals How New Weight-Loss Drugs Reshape the Brain
On May 6, 2026, In a study published in Nature, a team led by University of Virginia (UVA)…
-
USC launches transformational AI initiative with $200 million gift
On May 5, 2026, the University of Southern California (USC) announced a transformational initiative that will leverage AI…
-
Study Reports unprecedented view of the immune system’s killer cells
On May 4, 2026, a study conducted by the University of Geneva and the Lausanne University Hospital (CHUV)…
-
UCB to acquire Candid Therapeutics for more Than $2 Bllion, building upon its existing immunology pipeline
On May 3, 2026, UCB, a global biopharmaceutical company, announced signing of a definitive agreement under which it…
-
Canada approves second generic semaglutide, the first G7 country to do so
On May 1, 2026, Health Canada authorized a second generic semaglutide injection. Health Canada is currently reviewing seven other…
-
Researchers create groundbreaking first-draft map of genetic interactions within human cells
On Apr. 30, 2026, researchers at the University of Bonn and University Hospital Bonn have created a groundbreaking…
-
Biotechnology | Cloning | CRISPR | Genomics | Veterinary
Colossal Biosciences Is Working to Bring Back the Bluebuck, an Antelope Hunted to Extinction in 1800
On Apr. 30, 2026, Colossal Biosciences, the world’s de-extinction company, announced that it is working to de-extinct the…
-
Artificial Intelligence | Biotechnology | Diagnostics | Disease | Genomics | Neurology | Non-Profit Research | Oncology | Therapeutics
Biohub Launches the Virtual Biology Initiative to Galvanize a Global Effort to Create the Open Data Foundation for AI-Accelerated Biolog
On Apr. 29, 2026, Biohub announced the Virtual Biology Initiative, a landmark five-year initiative to galvanize a global…
-
Scientists Create First-Ever ‘Smell Map’
On Apr. 28, 2026, scientists Sandeep (Robert) Datta, professor of neurobiology in the Blavatnik Institute at Harvard Medical…
-
Mayo Clinic study points to changes decades before Alzheimer’s symptoms
On Apr. 28, 2026, new research from the Mayo Clinic show subtle biological changes linked to Alzheimer’s disease…
-
Biotechnology | Diagnostics | FDA | Neurology
U.S. FDA Grants Breakthrough Device Designation to Laguna Diagnostics’ mRNA Gene Biomarker Test to Aid in Differentiation of Schizophrenia and Bipolar I Disorder
On Apr. 28, 2026, Laguna Diagnostics announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough…
-
FDA Announces Major Steps to Implement Real-Time Clinical Trials
On Apr. 28, 2026, The U.S. Food and Drug Administration announced two major steps as part of an…
-
Purdue Pharma sentenced in connection with its 2020 Plea Agreement with U.S. Department of Justice
On Apr. 28, 2026, the U.S. District Court for the District of New Jersey sentenced Purdue Pharma in…
-
Sun Pharma, India’s Largest drug Firm to Buy U.S., to Acquire Organon for $11.75 Billion
On Apr. 27, 2026, Sun Pharmaceutical Industries and Organon announced they have entered into an agreement under which…
-
Princeton scientists make 3D bio-electronic hybrid system using brain cells
On Apr. 24, 2026, researchers at Princeton University announce they have developed a 3-dimensional device that merges living…
-
UK Trials Show Paxlovid speeds recovery, but doesn’t reduce hospitalization in vaccinated patients
On Apr. 23, 2026. two national trials published in the New England Journal of Medicine report Paxlovid (nirmatrelvir-ritonavir)…
-
Girl’s sight restored after ‘life-changing’ gene therapy
On Apr. 23, 2026, a research team at the University College London (UCL) and Great Ormond Street Hospital…
-
Biotechnology | Disease | FDA | Therapeutics
FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss
On Apr. 23, 2026, the U.S. Food and Drug Administration (FDA) approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual…
-
Researchers Develop DNA-Based Bio-Transistor Enabling Molecular Computation and Memory
On Apr. 22, 2026, the Korea Advanced Institute of Science and Technology (KAIST) announced that a research team…
-
U.S. Military Makes Flu Vaccine Optional
On Apr. 21, 2026, the annual influenza vaccines are no longer mandatory, said Pete Hegseth in a video…
-
Lilly to acquire Kelonia Therapeutics for $3.25 billion to advance in vivo CAR-T cell therapies
On Apr. 20, 2026, Eli Lilly and Kelonia Therapeutics, a clinical-stage biotechnology company pioneering in vivo gene delivery,…
-
Kailera nets $625M, biotech’s biggest-ever IPO
On Apr. 17, 2026, Kailera Therapeutics, a high-profile drug startup aiming to compete with Novo Nordisk and Eli…
